“The FDA's filing acceptance of Dr. Reddy's proposed denosumab biosimilar marks an important milestone in bringing this biosimilar medication to more patients throughout the U.S.,” said Milan ...

The deal is the latest in a series of Sanofi investments in its immunology portfolio. According to Sanfoi, DR-0201 can ...

Oxford Biotherapeutics Ltd. is partnering with Roche AG to expand the current field of tumor antigens that can be drugged with antibodies, as part of a potential $1 billion-plus agreement. The ...

Dr. Reddy’s Laboratories RDY and partner, Alvotech ALVO, announced the FDA’s acceptance of a regulatory filing, seeking the ...

seeking to block the entry of its BIIB800 biosimilar tocilizumab into the market and alleging infringement of various patents covering processes, methods of treatment, antibody subtypes ...

Novartis and Roche's big-selling eye drug Lucentis has its first biosimilar competitor in Europe ... and has developed a bispecific antibody - faricimab - that also provides less frequent ...

A doctor can order a lab test called an MMR titer to check your levels of measles antibodies, but health experts don’t always recommend this route and insurance coverage can vary. Getting ...

CEPI is partnering with Astrazeneca plc to advance VHH-based multispecific antibodies targeting influenza, while Harbour Biomed Ltd. has entered into a global strategic collaboration with Astrazeneca ...

Lap 1 – Sainz crashes out under the SC With Williams looking strong in the season opener, Carlos Sainz would have had hopes of a points finish. There was to be no such luck for last year’s ...

Simon Wentworth is a journalist and digital news editor at The Pharma Letter. Part of the editorial team since 2017, Simon is host of The Pharma Letter Podcast and has reported from major European and ...

Patients with diabetic macular edema previously treated with a ranibizumab biosimilar in India experience comparable safety and efficacy after being switched to another ranibizumab biosimilar, ...